These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 7263106)

  • 1. Lipid-lowering agents and their meaning in the treatment of the fat metabolism-atherosclerosis functional circle.
    Kuemmerle HP
    Int J Clin Pharmacol Ther Toxicol; 1981 Jul; 19(7):289-96. PubMed ID: 7263106
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The possible means for the pharmacological correction of lipid metabolic disorders in atherosclerosis].
    Piskun RP; Pentiuk AA; Serkova VK; Polesia TL; Savitskaia EA
    Eksp Klin Farmakol; 1997; 60(2):78-85. PubMed ID: 9206580
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Biochemical and experimental aspects of the lipid-lowering drugs pharmacology (author's transl)].
    Jacotot B
    Sem Hop; 1979 Dec 8-15; 55(41-42):1947-55. PubMed ID: 231322
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Mechanism of action of antilipemic drugs].
    Bruckert E; Turpin G
    Arch Mal Coeur Vaiss; 1992 Sep; 85 Spec No 2():109-12. PubMed ID: 1285687
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Biochemical and experimental aspects of the lipid-lowering drugs pharmacology (author's transl)].
    Jacotot B
    Pathol Biol (Paris); 1979 May; 27(5):305-13. PubMed ID: 388303
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Statins: from hypocholesteremic drugs to antiatherogenic agents].
    Manzoli A; Patti G; D'Ambrosio A; Montesanti R; Calabrese V; Abbate A; Gioia G; Di Sciascio G
    Clin Ter; 2001; 152(5):307-13. PubMed ID: 11794851
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmaceutical initiatives to combat atherosclerosis--what to do with the good, the bad, and the ugly lipoproteins.
    Samson RH
    Semin Vasc Surg; 2002 Dec; 15(4):204-15. PubMed ID: 12478495
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Prevention and therapy of arteriosclerosis (author's transl)].
    Hauss WH
    Aktuelle Gerontol; 1978 Dec; 8(12):653-60. PubMed ID: 33560
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathogenic mechanisms of atherosclerosis: effect of lipid lowering on the biology of atherosclerosis.
    Ganz P; Creager MA; Fang JC; McConnell MV; Lee RT; Libby P; Selwyn AP
    Am J Med; 1996 Oct; 101(4A):4A10S-16S. PubMed ID: 8900332
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intensive lipid lowering therapy and atherosclerosis.
    Jain P; Misra A
    Natl Med J India; 1992; 5(1):20-1. PubMed ID: 1304240
    [No Abstract]   [Full Text] [Related]  

  • 11. The use of lipid-lowering agents in HIV-infected patients.
    Meienberg F; Battegay E; Bucher HC; Battegay M
    J HIV Ther; 2001 May; 6(2):40-4. PubMed ID: 11501203
    [No Abstract]   [Full Text] [Related]  

  • 12. Atherogenesis in children: implications for the prevention of atherosclerosis.
    Olson RE
    Adv Pediatr; 2000; 47():55-78. PubMed ID: 10959440
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Lipid lowering therapy: new pathophysiologic aspects and clinical implications].
    Nordmann A; Martina B; Keller U; Battegay E
    Schweiz Med Wochenschr; 1998 Apr; 128(17):665-70. PubMed ID: 9622839
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dietary cholesterol, cholesterol absorption, postprandial lipemia and atherosclerosis.
    Huff MW
    Can J Clin Pharmacol; 2003; 10 Suppl A():26A-32A. PubMed ID: 14571303
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Verification of the lipid hypothesis by drug intervention].
    Levy RI
    Ter Arkh; 1985; 57(11):33-5. PubMed ID: 3909475
    [No Abstract]   [Full Text] [Related]  

  • 16. Lipid lowering therapy and stabilization of atherosclerotic plaques.
    Krone W; Müller-Wieland D
    Thromb Haemost; 1999 Sep; 82 Suppl 1():60-1. PubMed ID: 10695487
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Treatment of disorders of lipid metabolism--gastroenterologic aspects].
    Steinmetz A
    Z Arztl Fortbild (Jena); 1992 May; 86(9):437-44. PubMed ID: 1318619
    [No Abstract]   [Full Text] [Related]  

  • 18. [Dyslipidemia, lipid lowering drugs and thrombosis].
    Ambrosi P; Juhan-Vague I
    Arch Mal Coeur Vaiss; 1995 Nov; 88(11):1641-5. PubMed ID: 8746000
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of indicators for assessing the quality of prescribing of lipid-lowering drugs: data from the pharmacotherapeutic quality circles in Hesse, Germany.
    Schubert ; Köster ; Ihle P; von Ferber L
    Int J Clin Pharmacol Ther; 2001 Nov; 39(11):492-8. PubMed ID: 11727970
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [New studies: lipid regulation prevents development of atherosclerosis].
    Olsson AG
    Lakartidningen; 1991 Jun; 88(25):2289-92. PubMed ID: 2062130
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.